100
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Gynaecology

Laparoscopic assessment improves case selection for exenterative surgery in recurrent cervical and endometrial cancer

ORCID Icon, , &

References

  • Baiocchi G, Guimaraes GC, Rosa Oliveira RA, Kumagai LY, Faloppa CC, Aguiar S, et al. 2012. Prognostic factors in pelvic exenteration for gynecological malignancies. European Journal of Surgical Oncology : The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 38:948–954.
  • Brunschwig A. 1948. Complete excision of pelvic viscera for advanced carcinoma. A one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer 1:177–183.
  • Chatterjee S, Chen L, Jones N, Tergas AI, Burke WM, Hou JY, Wright JD. 2016. National trends in total pelvic exenteration for gynecologic malignancies. American Journal of Obstetrics and Gynecology 215:395–396.
  • Chiantera V, Rossi M, De Iaco P, Koehler C, Marnitz S, Fagotti A, et al. 2014. Morbidity after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 230 patients. International Journal of Gynecological Cancer : official Journal of the International Gynecological Cancer Society 24:156–164.
  • Diver EJ, Rauh-Hain JA, Del Carmen MG. 2012. Total pelvic exenteration for gynecologic malignancies. International Journal of Surgical Oncology 2012:693535.
  • Graves S, Seagle B-LL, Strohl AE, Shahabi S, Nieves-Neira W. 2017. Survival after pelvic exenteration for cervical cancer: a national cancer database study. International Journal of Gynecological Cancer : official Journal of the International Gynecological Cancer Society 27:390–395.
  • Höckel M, Dornhöfer N. 2006. Pelvic exenteration for gynaecological tumours: achievements and unanswered questions. The Lancet. Oncology 7:837–847.
  • Höckel M, Horn LC, Einenkel J. 2012. (Laterally) Extended endopelvic resection: surgical treatment of locally advanced and recurrent cancer of the uterine cervix and vagina based on ontogenetic anatomy. Gynecologic Oncology 127:297–302.
  • Jäger L, Nilsson PJ, Rådestad AF. 2013. Pelvic exenteration for recurrent gynecologic malignancy. International Journal of Gynecological Cancer 23:755–762.
  • Kaur M, Joniau S, D'Hoore A, Van Calster B, Van Limbergen E, Leunen K, et al. 2012. Pelvic exenterations for gynecological malignancies: a study of 36 cases. International Journal of Gynecological Cancer : official Journal of the International Gynecological Cancer Society 22:889–896.
  • Kaur M, Joniau S, D'Hoore A, Vergote I. 2014. Indications, techniques and outcomes for pelvic exenteration in gynecological malignancy. Current Opinion in Oncology 26:514–520.
  • Khoury-Collado F, Einstein MH, Bochner BH, Alektiar KM, Sonoda Y, Abu-Rustum NR, et al. 2012. Pelvic exenteration with curative intent for recurrent uterine malignancies. Gynecologic Oncology 124:42–47.
  • Köhler C, Tozzi R, Possover M, Schneider A. 2002. Explorative laparoscopy prior to exenterative surgery. Gynecologic Oncology 86:311–315.
  • Miller B, Morris M, Rutledge F, Mitchell MF, Atkinson EN, Burke TW, Wharton JT. 1993. Aborted exenterative procedures in recurrent cervical cancer. Gynecologic Oncology 50:94–99.
  • Peiretti M, Zapardiel I, Zanagnolo V, Landoni F, Morrow CP, Maggioni A. 2012. Management of recurrent cervical cancer: A review of the literature. Surgical Oncology 21:e59–e66.
  • Plante M, Roy M. 1998. Operative laparoscopy prior to a pelvic exenteration in patients with recurrent cervical cancer. Gynecologic Oncology 69:94–99.
  • Tanaka S, Nagase S, Kaiho-Sakuma M, Nagai T, Kurosawa H, Toyoshima M, et al. 2014. Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer. International Journal of Clinical Oncology 19:133–138.
  • Vargas HA, Burger I. a, Donati OF, Andikyan V, Lakhman Y, Goldman D. a, et al. 2013. Magnetic resonance imaging/positron emission tomography provides a roadmap for surgical planning and serves as a predictive biomarker in patients with recurrent gynecological cancers undergoing pelvic exenteration. International Journal of Gynecological Cancer: official Journal of the International Gynecological Cancer Society 23:1512–1519.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.